Exact Sciences Files Q3 2024 10-Q
Ticker: EXAS · Form: 10-Q · Filed: 2024-11-05T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
TL;DR
EXAS Q3 2024 10-Q filed. Financials for 9 months and Q3 ending Sept 30, 2024.
AI Summary
Exact Sciences Corp. reported its third-quarter 2024 results, with the filing dated November 5, 2024. The company's fiscal year ends on December 31st. Key financial data and reporting periods, including the nine months ended September 30, 2024, and the third quarter ended September 30, 2024, are detailed within this 10-Q filing.
Why It Matters
This filing provides investors with the latest financial performance and operational details for Exact Sciences, crucial for understanding the company's trajectory in the diagnostics sector.
Risk Assessment
Risk Level: medium — 10-Q filings are standard financial reports, but the specific financial health and market performance of Exact Sciences can introduce medium-level risk.
Key Numbers
- 20240930 — Reporting Period End (The company's financial performance is reported up to this date for the third quarter of 2024.)
- 20241105 — Filing Date (This is the date the 10-Q report was officially submitted to the SEC.)
Key Players & Entities
- EXACT SCIENCES CORP (company) — Filer
- 20240930 (date) — Reporting Period End Date
- 20241105 (date) — Filing Date
- 2024 Q3 (date) — Quarter
- 2024-09-30 (date) — Specific Reporting Date
- 2023-12-31 (date) — Previous Year End Date
- 2023-09-30 (date) — Previous Year Q3 End Date
FAQ
What is the primary purpose of this 10-Q filing?
This 10-Q filing provides a comprehensive quarterly financial report for Exact Sciences Corp., detailing its financial condition and results of operations for the period ended September 30, 2024.
What fiscal period does this 10-Q cover?
This 10-Q filing covers the third quarter of 2024, with the reporting period ending on September 30, 2024.
When was this 10-Q filing submitted to the SEC?
This 10-Q filing was submitted to the SEC on November 5, 2024.
What is the company's fiscal year end?
Exact Sciences Corp.'s fiscal year ends on December 31st.
What is the SIC code for Exact Sciences Corp.?
The Standard Industrial Classification (SIC) code for Exact Sciences Corp. is 8071, which falls under SERVICES-MEDICAL LABORATORIES.
From the Filing
0001124140-24-000083.txt : 20241105 0001124140-24-000083.hdr.sgml : 20241105 20241105170843 ACCESSION NUMBER: 0001124140-24-000083 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 105 CONFORMED PERIOD OF REPORT: 20240930 FILED AS OF DATE: 20241105 DATE AS OF CHANGE: 20241105 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EXACT SCIENCES CORP CENTRAL INDEX KEY: 0001124140 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 204782291 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-35092 FILM NUMBER: 241428480 BUSINESS ADDRESS: STREET 1: 5505 ENDEAVOR LANE CITY: MADISON STATE: WI ZIP: 53719 BUSINESS PHONE: 608-284-5700 MAIL ADDRESS: STREET 1: 5505 ENDEAVOR LANE CITY: MADISON STATE: WI ZIP: 53719 FORMER COMPANY: FORMER CONFORMED NAME: EXACT CORP DATE OF NAME CHANGE: 20000919 10-Q 1 exas-20240930.htm 10-Q exas-20240930 2024 Q3 0001124140 false --12-31 http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent 1 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure exas:position exas:segment 0001124140 2024-01-01 2024-09-30 0001124140 2024-11-04 0001124140 2024-09-30 0001124140 2023-12-31 0001124140 2024-07-01 2024-09-30 0001124140 2023-07-01 2023-09-30 0001124140 2023-01-01 2023-09-30 0001124140 us-gaap:CommonStockMember 2023-12-31 0001124140 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001124140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001124140 us-gaap:RetainedEarningsMember 2023-12-31 0001124140 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001124140 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001124140 2024-01-01 2024-03-31 0001124140 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001124140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001124140 us-gaap:CommonStockMember 2024-03-31 0001124140 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001124140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001124140 us-gaap:RetainedEarningsMember 2024-03-31 0001124140 2024-03-31 0001124140 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001124140 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001124140 2024-04-01 2024-06-30 0001124140 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001124140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0001124140 us-gaap:CommonStockMember 2024-06-30 0001124140 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001124140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001124140 us-gaap:RetainedEarningsMember 2024-06-30 0001124140 2024-06-30 0001124140 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001124140 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001124140 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001124140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-30 0001124140 us-gaap:CommonStockMember 2024-09-30 0001124140 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001124140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0001124140 us-gaap:RetainedEarningsMember 2024-09-30 0001124140 2023-09-30 0001124140 us-gaap:CommonStockMember 2022-12-31 0001124140 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001124140 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001124140 us-gaap:RetainedEarningsMember 2022-12-31 0001124140 2022-12-31 0001124140 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001124140 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001124140 2023-01-01 2023-03-31 0001124140 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001124140 us-gaap:AccumulatedOtherCompre